CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  
jump over right navigation bar
TB Notes 1, 2008
Director's Letter
Highlights from State and Local Programs
  TB Outreach Educator Honored
  TB Legal Forum for Southwestern Border States
  Effecting Acute Isolation of TB patients Utililizing Chicago Department of Public Health Emergency Quarantine and Isolation Regulations
The 2007 Pacific Island Tuberculosis Controllers Association Meeting
Revision of Technical Instructions for Panel Physicians
National Tuberculosis Indicators Project (NTIP): Intensive Review
TB Education and Training Network Updates
  New Column! - Ask the Experts
  Member Highlights
  Cultural Competency Update
Communications, Education, and Behavioral Studies Branch Update
  2007 Program Managers Course
Clinical and Health Systems Research Branch Updates
  A New Resource to Help Employers Prevent TB
Surveillance, Epidemiology, and Outbreak Investigations Branch Updates
  An Evaluation of Surveillance for Multidrug-Resistant Tuberculosis: Texas, 2000-2006
  TB Epidemiologic Studies Consortium's "Translating Research into Practice" (TRiP) Workgroup
  TBESC Task Order 6 (TO6) Update: Regional Capacity Building in Low-Incidence Areas
  TB Biotechnology Engagement Project (BTEP #72), Armenia and Georgia, 2003-2007
New CDC Publications
Personnel Notes
Calendar of Events
 
Return to Table of Contents

TB Notes Newsletter

No. 1, 2008

Revision of Technical Instructions for Panel Physicians

The Division of Global Migration and Quarantine (DGMQ) has completed the revision of the Technical Instructions for panel physicians. Since 2005, DGMQ has been working with DTBE to review scientific literature on overseas pre-immigration medical screening and develop new algorithms. Input was also solicited from the U.S. tuberculosis community. The 2007 Technical Instructions for Tuberculosis Screening and Treatment (TB TIs) provide a modernized approach to TB screening overseas for U.S. immigration applicants. For the first time, mycobacterial cultures will be required for applicants suspected of having TB disease. Moreover, drug susceptibility testing (DST) on positive isolates and directly observed therapy (DOT) according to CDC / American Thoracic Society (ATS) / Infectious Diseases Society of America (IDSA) standards will be required for applicants with TB disease. It is expected that implementation of the 2007 TB TIs should help prevent importation of TB into the United States, improve U.S. domestic TB control, and increase TB infrastructure globally.

The 2007 TB TIs were first implemented in April 2007 for the screening of 14,000 Burmese refugees from Thailand who were to be resettled to the United States. The 2007 TB TIs have also been recently implemented for all applicants from Mexico and the Philippines. Global implementation will occur over the next several years, beginning in priority countries determined by immigration patterns, refugee resettlements, burden of TB, and U.S. domestic foreign-born TB case rates.

—Reported by Drew Posey, MD
Div of Global Migration and Quarantine

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333